» Articles » PMID: 27398827

The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia

Overview
Specialty Pulmonary Medicine
Date 2016 Jul 12
PMID 27398827
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Comorbidities, age, severity of illness, and high risk pathogens are well-known outcome determinants in community-acquired pneumonia (CAP). How these factors interact has not yet been clarified.

Objectives: We conducted this study to analyze the complex interaction of comorbidities, age, illness severity, and pathogens in relation to CAP.

Methods: We performed a secondary analysis of the Community-Acquired Pneumonia Organization database to evaluate the impact of age in different age groups (<65, 65-79, and ≥80 yr), comorbidities (malignant disease, chronic obstructive pulmonary disease, renal and liver disease, cerebrovascular accident, congestive heart failure, and diabetes mellitus), severity of illness at admission, and etiology on the mortality of patients admitted to the hospital with CAP.

Measurements And Main Results: A total of 6,205 patients met the inclusion criteria, and 508 (8.2%) died within 30 days. Factors independently associated with mortality were malignant disease, congestive heart failure, cerebrovascular accident, renal disease, diabetes mellitus, altered mental status, hypoxemia, pleural effusion, hematocrit less than 30%, requirement for mechanical ventilation, and being age 80 years and older. A total of 1,699 pathogens were defined in 1,545 cases; the etiology was the same for all age groups. In the overall population, mortality increased with age, but etiology was not associated with mortality. When we analyzed the patients with one comorbidity or less, we found that mortality was not different between patients younger than 65 old and those 65-79 years old, but it was higher for those aged 80 years and older.

Conclusions: The presence of comorbidities is associated with poorer outcomes in CAP. However, when one comorbidity or less was present, we found that being age 80 years or older was a factor that increased mortality. From a clinical standpoint, this study suggests that being age 80 years or older, instead of age 65 years and older, should be considered a risk factor for poor outcome in CAP.

Citing Articles

Minimally Invasive Aortic Valve Replacement: Case Series Study.

Karic A, Avdagic H, Kalinic N, Busevac E, Krajnovic A, Sokolovic S Med Arch. 2025; 78(4):305-308.

PMID: 39981148 PMC: 11838833. DOI: 10.5455/medarh.2024.78.305-308.


A retrospective analysis of mental well-being, nutritional status, and comorbidity burden in elderly patients with community-acquired pneumonia.

Liao J, Hong J, Miao L, Shen X, Xie C BMC Public Health. 2025; 25(1):667.

PMID: 39966810 PMC: 11837668. DOI: 10.1186/s12889-025-21970-7.


The incremental value of aspartate aminotransferase/alanine aminotransferase ratio combined with CURB-65 in predicting treatment outcomes in hospitalized adult community-acquired pneumonia patients with type 2 diabetes mellitus.

Zhou H, Zhu X, Zhang Y, Xu W, Li S BMC Pulm Med. 2025; 25(1):26.

PMID: 39825277 PMC: 11742778. DOI: 10.1186/s12890-025-03488-1.


A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.

Branche A, Ramesh M, Francis B Infect Dis Ther. 2024; 14(Suppl 1):39-61.

PMID: 39739198 PMC: 11724830. DOI: 10.1007/s40121-024-01081-3.


Rapid Molecular Diagnostics of Pneumonia Caused by Gram-Negative Bacteria: A Clinician's Review.

Pintea-Simon I, Bancu L, Mare A, Ciurea C, Toma F, Man A Antibiotics (Basel). 2024; 13(9).

PMID: 39334980 PMC: 11429159. DOI: 10.3390/antibiotics13090805.